ARCHIVES

DeVita Suggest Chop Should Be Expanded, Given Long Term Status, But Only With A “Quid Pro Quo”

This article is from The Cancer Letter archive.

Vol. 07 No. 12 | March 20, 1981

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored

December 10, 1982

Study Underway To Help Childhood Cancer Survivors With Learning Difficulties

October 26, 2001

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

NCI Cooperative Groups Recognized By ASCO For 50+ Years Of Clinical Trials.

June 1, 2007